TAMPA, Fla., Sept. 14, 2005 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), a leading source of low-cost prescription medications for millions of Americans who have no prescription insurance coverage, announced today that that the company is hiring corporate officers to lead the prescription drug division.
Rx Processing Corp. has been actively recruiting corporate officers in the prescription drug division since the first quarter. The caliber of the corporate officers Rx Processing Corp. has been courting share common goals and are veterans of increasing shareholder value. Their mission is to lead the prescription drug division into the future with the resources and knowledge needed to affect the efficient distribution of prescription drugs and lab tests through brick and mortar storefronts in America.
Peter Fiorillo, CEO of Rx Processing commented, "I have been working on building the prescription drug division for long-term growth in the aggressive prescription drug industry. As the driving force behind Rx Processing Corp., I have taken my time to recruit a set of corporate officers that share my vision of `affordable prescription drugs for all mankind, without prejudice.' I am very pleased to say we are within a week of signing the corporate officers' contracts."
Background information on the corporate officers will be posted by the middle of next week on www.Rxprocessingcorp.com.
About Rx Processing
Rx Processing is positioned to become a market leader in providing prescription drugs, lab tests and drug tests to U.S. citizens, corporations, unions, and members through FDA-approved patient service centers for their lab testing and licensed pharmacies in the United States and Canada. The Company provides access to approved brand name and generic medications as well as over 1,000 lab tests through storefront locations with access to 4,000 FDA-approved patient service centers for their lab testing. Rx Processing estimates that more than 40 million Americans could benefit from the company's low-cost prescription drugs, lab testing and drug screening
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.